¶¶ÒõÈÈÃÅ

  1. Home
  2. ¶¶ÒõÈÈÃÅ Promotes & Advances the Microbial Sciences
  3. ¶¶ÒõÈÈÃÅ's Strategic Roadmap
  4. ¶¶ÒõÈÈÃÅ Health
  5. Phage Therapy Coordination Network

¶¶ÒõÈÈÃÅ Health

Phage Therapy
Coordination Network

Unlocking Bacteriophage Therapies for Antimicrobial Resistance (AMR) Through Coordinated Access and Regulatory Approvals

Phage Therapy Coordination Network

Executive Summary

Bacteriophage therapy offers life-saving potential against drug-resistant infections but remains limited by scientific and clinical complexity, uncertainty in dosing burden, scalable manufacturing, fragmented data collection processes, unclear regulations and accessibility gaps. ¶¶ÒõÈÈÃÅ Health’s Phage Therapy Coordination Initiative will streamline data collection, align regulatory pathways and support multicenter trials. By uniting science, clinical practice and policy, ¶¶ÒõÈÈÃÅ aims to move phage therapy from isolated use to scalable national readiness. This coordinated approach can unlock scalable, equitable and regulatory-aligned access to phage therapies.

Click diagram to expand

Join the Clinical Use Guidance Working Group

The Clinical Use Guidance Working Group is accepting applicants now through Aug. 31, 2026. This group will focus on developing practical tools and consensus recommendations to support the implementation of phage therapy in U.S. hospital settings.​ If you are interested in joining our efforts, apply today!

Membership Update

Extended Network: Join the PTCN Extended Network to stay informed and engaged. Click the button below to express interest in joining.

Shaping the Future of Phage Therapy​

In Spring 2026, the ¶¶ÒõÈÈÃÅ Health Unit kicked-off the Phage Therapy Coordination Network (PTCN) initiative by convening clinicians, researchers, regulators and manufacturers with a shared goal of expanding reliable, safe and timely patient access to phage therapy.​ The meeting was designed to surface where the system breaks down today and where coordinated action could make the greatest impact in the near- and medium-term. 
Read Key Takeaways From the Kickoff Meeting

Projects and Working Groups

Now, we are launching 4 multidisciplinary working groups to identify the practical, regulatory, operational and technical requirements needed to scale phage therapy in the U.S. Together, these groups will generate the standards, workflows, guidance and implementation frameworks that will inform the development of the Phage Therapy Coordination Platform (PTCP), a national coordination infrastructure designed to connect clinicians, laboratories, phage repositories, manufacturers and regulators.

 

Read More About Our Approach

Working Group Focus Areas

  1. Clinical Use Guidance—Best practices and decision-support tools for safe clinical implementation.​ This group is now accepting applicants. Read more below!
  2. Phage-Matching Workflow Integration—Standardized approaches for isolate characterization and phage matching.​
  3. Manufacturing Quality & CMC Standards—Minimum viable standards for producing regulator-ready phage products.​
  4. Regulatory Pathways & Implementation Playbook—Operational and regulatory guidance to support hospital adoption.​

Get Involved

¶¶ÒõÈÈÃÅ Health is seeking experts to participate in the Clinical Use Guidance Working Group. Applications are due by Aug. 31, 2026.

From Working Groups to Infrastructure

The outputs of these working groups will serve as foundational building blocks for PTCP, helping define how data, workflows, evidence and stakeholders can be coordinated to accelerate patient access to phage therapy nationwide.

Phage therapy is the use case. Coordination infrastructure is the product. Patient access is the outcome.

Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) Abstracts Due Soon

Save 50% on ¶¶ÒõÈÈÃÅ Membership

Use code 50OFF2026 to save on membership

Get published in an ¶¶ÒõÈÈÃÅ journal